Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia

Antimicrobial Resistance (AMR) is a growing global health crisis, requiring urgent action. A study by the Centre for Impact Investing and Practices, GAEA, and PAA aims to explore social, economic, and environmental factors contributing to AMR in Asia’s healthcare and agriculture sectors. The report identifies financing shortfalls in clinical development and healthcare systems and advocates for collaborative action among investors, philanthropists, and companies. It highlights the need for a multi-system approach focusing on education, prevention, monitoring, and treatment.